JP2005323968A - Erythrocytic type cancer, viral/bacterial infectious disease treatment instrument - Google Patents
Erythrocytic type cancer, viral/bacterial infectious disease treatment instrument Download PDFInfo
- Publication number
- JP2005323968A JP2005323968A JP2004171890A JP2004171890A JP2005323968A JP 2005323968 A JP2005323968 A JP 2005323968A JP 2004171890 A JP2004171890 A JP 2004171890A JP 2004171890 A JP2004171890 A JP 2004171890A JP 2005323968 A JP2005323968 A JP 2005323968A
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- membrane
- viral
- instrument
- treatment instrument
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
本発明は、医学の分野に属する発明である。本発明は大きさ、形状、性質を赤血球と同様に造ったものである。膜骨格上に、異常なDNA又はRNAを感知するセンサーと、細胞膜や核膜、細胞壁、ウイルスの殻を貫き、核酸分解酵素を注入する管を取り付けた装置である。本発明は、生理的食塩水に混ぜ、点滴方式で静脈から体内に入れて使用する。 The present invention belongs to the medical field. The present invention has the same size, shape and properties as those of red blood cells. This is a device in which a sensor that senses abnormal DNA or RNA and a tube that penetrates the cell membrane, nuclear membrane, cell wall, and virus shell and injects a nucleolytic enzyme are attached on the membrane skeleton. The present invention is mixed with physiological saline and used by instilling into the body from a vein.
本発明は、新しい技術を利用した発明であり、比較する技術は存在していない。 The present invention uses a new technology, and there is no technology for comparison.
癌にかかっても、手術を行なわなくても良いようにする。また、副作用が出ないものにする。そして、癌やウイルス・細菌感染症を完全に治療できるようにする。 Try not to have surgery if you have cancer. Also, make sure there are no side effects. And to be able to completely treat cancer and viral / bacterial infections.
本発明は、血管を通り体内から患部を治していくので、手術を行う必要がない。さらに、異常なDNA又はRNAをもつものしか破壊しないので、正常な細胞を破壊することがなく、副作用が出ない。本発明は、全身の血管を通るので、癌細胞やウイルス、細菌がどこに存在していても治療できる。さらに、癌においては転移があっても治療できる。 In the present invention, since the affected part is cured from the body through the blood vessel, it is not necessary to perform an operation. Furthermore, since only those having abnormal DNA or RNA are destroyed, normal cells are not destroyed, and no side effects occur. Since the present invention passes through blood vessels throughout the body, it can be treated where cancer cells, viruses, and bacteria are present. Furthermore, cancer can be treated even if there is metastasis.
本発明により、上記に示したような効果が得られる。 According to the present invention, the effects as described above can be obtained.
本装置の直径は7μm、厚さは2μmであり、膜骨格や膜、管は分子レベルでの製造になるため、原子を見られる顕微鏡を用いての作業になる。膜骨格は、装置がパラシュート型や砲弾型に変形し、毛細血管を通過できるようにする。センサーと管は、装置に納まる大きさとし、管はできるだけ細くし、細菌が持つ細胞壁やウイルスが持つ殻を貫けるほど硬いもので、伸ばせるようにする。そして、白血球に外敵と見なされないようにするために膜の表面に血液型物質を付ける。素材は、膜骨格、膜は赤血球と同様で、センサー、管、管台は体内で無害な物質に分解されるものとする。管は、膜が壊される時に一緒に壊されるようにする。 This device has a diameter of 7 μm and a thickness of 2 μm. Since the membrane skeleton, membrane, and tube are manufactured at the molecular level, the operation is performed using a microscope that can see atoms. The membrane skeleton allows the device to be transformed into a parachute type or a shell type so that it can pass through capillaries. The sensor and tube should be sized to fit in the device, and the tube should be as thin as possible, so that it will be hard enough to penetrate the cell walls of bacteria and the shell of viruses, and be stretchable. Then, a blood type substance is attached to the surface of the membrane so that the white blood cells are not regarded as foreign enemies. The material is the membrane skeleton, the membrane is the same as red blood cells, and the sensor, tube, and nozzle are broken down into harmless substances in the body. The tubes are broken together when the membrane is broken.
初めに、別々に膜骨格、センサー、管を造る。次に、膜骨格上に管台、管、センサーを取り付ける。そして、核酸分解酵素を入れ、膜で覆う。最後に、血液型物質を膜上に付ける。 First, build the membrane skeleton, sensor, and tube separately. Next, a nozzle, a tube, and a sensor are attached on the membrane skeleton. Then, nuclease is put and covered with a membrane. Finally, a blood group substance is applied on the membrane.
1 センサー
2 管
3 膜骨格
4 管台1
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004171890A JP2005323968A (en) | 2004-05-14 | 2004-05-14 | Erythrocytic type cancer, viral/bacterial infectious disease treatment instrument |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004171890A JP2005323968A (en) | 2004-05-14 | 2004-05-14 | Erythrocytic type cancer, viral/bacterial infectious disease treatment instrument |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2005323968A true JP2005323968A (en) | 2005-11-24 |
Family
ID=35470771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004171890A Pending JP2005323968A (en) | 2004-05-14 | 2004-05-14 | Erythrocytic type cancer, viral/bacterial infectious disease treatment instrument |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2005323968A (en) |
-
2004
- 2004-05-14 JP JP2004171890A patent/JP2005323968A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zeng et al. | Super‐mini percutaneous nephrolithotomy (SMP): a new concept in technique and instrumentation | |
VILLÁNYI et al. | Short-term changes in renal function after extracorporeal shock wave lithotripsy in children | |
JP7466594B2 (en) | Systems and devices for administering substances | |
CN102698354A (en) | Double-sacculus conduit for thrombolysis | |
CN106265679A (en) | Bromine domain protein inhibitor is preparing the purposes that anti-HIV-1 is hidden in medicine | |
Zubor et al. | Cold atmospheric pressure plasma (CAP) as a new tool for the management of vulva cancer and vulvar premalignant lesions in gynaecological oncology | |
Zhang et al. | Ultrasound‐microbubble cavitation facilitates adeno‐associated virus mediated cochlear gene transfection across the round‐window membrane | |
Yang et al. | Neuroinflammation of microglia polarization in intracerebral hemorrhage and its potential targets for intervention | |
CN202620464U (en) | Ozone and ultrasonic combined gynecology treatment device | |
CN104667439A (en) | Focusing ultrasonic treatment head and ultrasonic treatment equipment | |
JP2005323968A (en) | Erythrocytic type cancer, viral/bacterial infectious disease treatment instrument | |
CN112912127A (en) | Tethered ultrasound devices and uses thereof | |
CN102697631A (en) | Ozone and ultrasonic combined gynecological treatment device | |
KR102232757B1 (en) | Delivery device of target material using extracorporeal shock wave | |
CN108578693A (en) | Photochemical method for preparation for the autologous plasma inactivated vaccine for treating AIDS | |
CN109498809A (en) | One kind containing nanometer gold bar-curing agent and preparation method for vascular malformation treatment | |
CN103170023A (en) | AIDS therapeutic equipment and manufacturing method | |
CN101912306A (en) | Device for rercutaneous interventional minimally-invasive treatment of tuberculosis focus in vivo | |
CA2298041A1 (en) | Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery | |
Zheng et al. | COMPARATIVE ANALYSIS OF GENE TRANSFER TO HUMAN AND RAT RETINAL PIGMENT EPITHELIUM CELL LINE BY A COMBINATORIA! USE OF RECOMBINANT ADENO-ASSOCIATED VIRUS AND ULTRASOUND OR/AND MICROBUBBLES | |
CN105687203B (en) | Applications of the cholecystokinin receptor inhibitor Devazepide in anti-fibrosis medicine preparation is prepared | |
Tarar | A Review on Key Modulatory Novel Features, Viral Assembly, Biomarkers Associated with Biological Replication and Molecular Genetics in Progression of Coronaviruses | |
CN206229822U (en) | A kind of Dispoable medical consumptive material automatic loading and unloading and destruction system | |
Miller et al. | Plasma Dose for Clinical Applications: New Considerations | |
Taneja | Re: Nanoparticle-Enabled Selective Destruction of Prostate Tumor Using MRI-Guided Focal Photothermal Therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20061020 |
|
A131 | Notification of reasons for refusal |
Effective date: 20061114 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
A02 | Decision of refusal |
Effective date: 20070410 Free format text: JAPANESE INTERMEDIATE CODE: A02 |